Head and Neck Cancers
6 protocols meet the specified criteria.
-
20324
ON-TRK: PrOspective Non-Interventional Study in Patients with Locally Advanced or Metastatic TRK Fusion Cancer Treated with Larotrectinib -
A151804
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events -
EAY191
Molecular Analysis for Combination Therapy Choice (ComboMATCH) -
RTOG1216
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck -
S2013
Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study -
WVU011118
Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry